A Pilot Study of the Impact of a Single Dose of Zoledronic Acid on Biomarkers in Breast Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2018
At a glance
- Drugs Zoledronic acid (Primary)
- Indications Breast cancer
- Focus Biomarker; Therapeutic Use
- 01 Jun 2018 Planned End Date changed from 1 May 2018 to 1 Apr 2019.
- 01 Jun 2018 Planned primary completion date changed from 1 May 2018 to 1 Apr 2019.
- 10 Jun 2017 Biomarkers information updated